Literature DB >> 15145615

Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage.

Kenneth E Hill1, Lauren V Zollinger, Hilary E Watt, Noel G Carlson, John W Rose.   

Abstract

Inducible nitric oxide synthase (iNOS) is an enzyme that produces nitric oxide (NO) and is thought to contribute to the pathogenesis of multiple sclerosis (MS). The extent of iNOS expression was examined using laser scanning confocal microscopy of 13 chronic active plaques from seven MS patients displaying both acute demyelination and active inflammation. iNOS expression in these plaques was substantial and diverse in cellular distribution. Expression of iNOS was observed in ependymal cells located in periventricular lesions, inflammatory cells, and occasionally in astrocytes. iNOS was found in microglial/macrophage cells that expressed CD64, the high affinity Fc gamma receptor associated with cells that have phagocytic function and participate in antibody-dependent cellular cytotoxicity (ADCC). Scavenger microglial/macrophage cells that expressed the marker CD14 were also present and may express iNOS. The markers for myelin damage, nitrotyrosine (an index of iNOS mediated damage via peroxynitrite formation), along with MBP fragments, were also observed associated with iNOS in MS plaques. Together, these findings support a central role for iNOS in the pathogenesis of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145615     DOI: 10.1016/j.jneuroim.2004.02.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  46 in total

1.  Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis.

Authors:  Lauren V Zollinger; Tae Ho Kim; Kenneth Hill; Eun K Jeong; John W Rose
Journal:  J Magn Reson Imaging       Date:  2011-03       Impact factor: 4.813

Review 2.  The executioners sing a new song: killer caspases activate microglia.

Authors:  J L Venero; M A Burguillos; P Brundin; B Joseph
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

Review 3.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

Review 4.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 5.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

6.  Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis.

Authors:  K Rejdak; A Petzold; T Kocki; J Kurzepa; P Grieb; W A Turski; Z Stelmasiak
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

Review 7.  Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis.

Authors:  Carin Waslo; Dennis Bourdette; Nora Gray; Kirsten Wright; Rebecca Spain
Journal:  Curr Treat Options Neurol       Date:  2019-05-06       Impact factor: 3.598

8.  Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.

Authors:  Alexandre S Basso; Dan Frenkel; Francisco J Quintana; Frederico A Costa-Pinto; Sanja Petrovic-Stojkovic; Lindsay Puckett; Alon Monsonego; Amnon Bar-Shir; Yoni Engel; Michael Gozin; Howard L Weiner
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

9.  Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation.

Authors:  Henrik Wilms; Jobst Sievers; Uta Rickert; Martin Rostami-Yazdi; Ulrich Mrowietz; Ralph Lucius
Journal:  J Neuroinflammation       Date:  2010-05-19       Impact factor: 8.322

10.  Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death.

Authors:  Noel G Carlson; Monica A Rojas; Jonathan W Redd; Philip Tang; Blair Wood; Kenneth E Hill; John W Rose
Journal:  J Neuroinflammation       Date:  2010-04-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.